NCT05993247View on ClinicalTrials.gov

Efficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients

PHASE2UnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 20, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2025

Conditions
Osteoarthritis
Interventions
COMBINATION_PRODUCT

Probiotics capsule

Subjects will take a probiotics combination capsule (Bacillus Subtilis 150 mg /Clostridium Burtyricum Toa 150 mg /Saccharomyces Boulardii 113 mg) three times a day for 8 weeks in combination with NSAIDs

COMBINATION_PRODUCT

Placebo capsule

Subjects will take a placebo capsule identical in shape and size to probiotics capsule three times a day for 8 weeks in combination with NSAIDs

Sponsors
All Listed Sponsors
collaborator

Daewoong Pharmaceutical Co. LTD.

INDUSTRY

lead

Jae Myung Park

OTHER

NCT05993247 - Efficacy of Probiotics for NSAID-induced Enteropathy in Arthritis Patients | Biotech Hunter | Biotech Hunter